Market Closed -
Japan Exchange
02:00:00 2024-06-07 EDT
5-day change
1st Jan Change
1,231
JPY
-0.32%
+4.23%
+11.20%
Nipro Corporation's Equity Buyback announced on July 3, 2018 has expired with 3,520,600 shares for ¥4,999.92 million.
The company expired its plan on November 21, 2018.
Jefferies Adjusts Nipro’s Price Target to 1,400 Yen From 1,200 Yen, Keeps at Hold
04-12
MT
Jefferies Adjusts Nipro's Price Target to 1,200 Yen From 1,000 Yen, Keeps at Hold
01-11
MT
Jefferies Adjusts Nipro’s Price Target to 1,000 Yen From 1,100 Yen, Keeps at Hold
23-07-24
MT
Nipro Corporation Reports Earnings Results for the Full Year Ended March 31, 2023
23-05-11
CI
Nanotis Corporation announced that it has received funding from Nipro Corporation
22-07-04
CI
Shinsei Bank : Japan's Topix hits highest since 1990 on hopes of new govt, better earnings
21-09-10
RE
SBI : Japan shares rally on, Topix hits over 30-year high on earnings optimism
21-09-09
RE
Azgard Nine : Japan to consider sharing COVID-19 vaccines amid calls to help Taiwan
21-05-27
RE
AstraZeneca : Nipro to Manufacture AstraZeneca's COVID-19 Vaccine in Japan
21-05-26
MT
AstraZeneca : Nipro sign COVID-19 vaccine deal for supply in Japan
21-05-26
RE
Qol Holdings Co., Ltd. acquired remaining 49% stake in Nichihos Co.,Ltd. from Nipro Corporation.
21-04-08
CI
Nipro : Syringe shortage hampers Japan's COVID-19 vaccination roll out
21-02-15
RE
Nippon Electric Glass : Glass maker Schott predicts enough vials to go around for COVID-19 vaccines
21-01-20
RE
Exclusive: Bottlenecks? Glass vial makers prepare for COVID-19 vaccine
20-06-12
RE
JMI Syringes & Medical Devices Limited announced that it has received BDT 1.82151 billion in funding from Nipro Corporation
19-07-02
CI
Nagase & Co., Ltd. cancelled the acquisition of 5% stake in Yuki Gosei Kogyo Co., Ltd. from Nipro Corporation.
19-03-26
CI
JMI Syringes & Medical Devices Limited announced that it expects to receive BDT 1.82151 billion in funding from Nipro Corporation
19-01-02
CI
Tranche Update on Nipro Corporation's Equity Buyback Plan announced on July 3, 2018.
18-11-22
CI
Nipro Corporation's Equity Buyback announced on July 3, 2018 has expired with 3,520,600 shares for ¥4,999.92 million.
18-11-20
CI
Tranche Update on Nipro Corporation's Equity Buyback Plan announced on July 3, 2018.
18-10-01
CI
Samsung Electronics Plans To Sell Medical Unit To Nipro
18-09-20
CI
Nipro Corporation announces an Equity Buyback for 4,000,000 shares, representing 2.4% for ¥5,000 million.
18-07-03
CI
Nipro Corporation authorizes a Buyback Plan.
18-07-02
CI
Nipro Corporation Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2018; Provides Consolidated Earnings Guidance for the Six Months Ending September 30, 2018 and Year Ending March 31, 2019
18-05-09
CI
Nagase & Co., Ltd. agreed to acquire 5% stake in Yuki Gosei Kogyo Co., Ltd. from Nipro Corporation for approximately ¥380 million.
18-03-26
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
NIPRO CORPORATION is a manufacturer of medical devices, pharmaceuticals and instrument products. The Company has three segments. The Medical-Related segment involves in the sale of injections and infusions, artificial organs, high function and dialysis related medical equipment, and diabetes, generics and kits related medicine products in Japan, as well as the sales of medical devices for injection and infusion, artificial organs and diabetes in overseas markets. The Pharmaceutical-Related segment involves in the manufacture and sale of pharmaceuticals. The Pharma Packaging segment sells glass for vials and ampoules as medical glass in Japan, thermos glass for lighting and glass for lighting equipment.
More about the company
Last Close Price
1,231
JPY
Average target price
1,470
JPY
Spread / Average Target
+19.42%
Consensus
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1